Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7440 p209
24 February 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


First prescriptions written by pharmacist independent prescribers in primary care

Paul Saxby

Beth Hird

Independent prescriber Beth Hird

Beth Hird, senior practice pharmacist at Nottinghamshire County Teaching Primary Care Trust, became the first pharmacist in England to write a prescription independently this week. She was also the first pharmacist to register as an independent prescriber with the Royal Pharmaceutical Society (PJ, 20 January, p63).

Mrs Hird runs a weekly asthma clinic at a medical practice in Nottingham. This week she prescribed a salbutamol inhaler for a patient during an annual asthma review.

“I was confident that this patient had asthma and that salbutamol was required. After carrying out my usual assessment and discussion with the patient I was also confident that the patient needed to continue their treatment,” explained Mrs Hird. The process was easier than supplementary prescribing because no clinical management plan was generated before the clinic — all other processes and assessments remained the same, she added.

To date, Mrs Hird is the only pharmacist registered in Britain as an independent prescriber. In Northern Ireland, Emma Quinn, locality prescribing adviser at South and East Belfast Eastern Health and Social Services Board, wrote her first prescription as an independent prescriber last week. She prescribed bendroflumethiazide to treat hypertension in a patient who had attended her weekly cardiovascular risk management clinic.

Ms Quinn, along with four other pharmacists, registered with the Pharmaceutical Society of Northern Ireland earlier this year (PJ, 27 January, p103 (PDF 80K)).

In January, the Northern Ireland Centre for Postgraduate Education and Training at Queen’s University Belfast became the first course in the UK to be fully accredited to provide an independent prescribing programme.

Back to Top


©The Pharmaceutical Journal